Scientists at San Diego-based Camino Pharma, Sanford Burnham Prebys and UC San Diego School of Medicine have received a $9 million grant from the National Institute on Drug Abuse for work on a drug intended to treat nicotine addiction.
The US NIH unit National Institute on Drug Abuse (NIDA) has granted an award of $9m for researchers to advance drug, SBP-9330, to treat nicotine addiction.
/PRNewswire/ Camino Pharma, LLC, a biotech company focused on finding cures for cancer and brain disorders, announced today that its co-founder and CSO,.
San Diego-based Camino Pharma, which is developing biotechnology focused on cancer and brain disorders, says it has received a $1.97M Small Business Innovation Research (SBIR) grant. The company said